Delivery Order SPE2DX22D0010-SPE2D826FCY39
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,584.17 to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 20 mg, with a completion date of December 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,737.63 to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with an ultimate completion date of February 4, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The awardee, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal pharmaceutical procurement and fulfills this delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,700.25 to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended-Release Capsules 25mg. This firm fixed-price, non-set-aside contract was awarded on February 2, 2026, with an ultimate completion date of February 3, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,137.71. This competitively awarded, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg, with a ceiling value of $1,510.71 and a completion date of January 6, 2026. This delivery order represents a firm fixed price contract with no set-aside designation, competitively awarded under an existing Indefinite Delivery Contract vehicle. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,459.67 and is scheduled for completion by December 19, 2025. The contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,408.02 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25 mg, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems....
- The Defense Logistics Agency Medical Supply Chain awarded a $2,727.34 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) Extended-Release Capsules, 20mg, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The order was placed at the contractor's primary location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 10mg, with a contract ceiling value of $2,071.44 and a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 25mg, with a ceiling value of $4,993.24. This is a firm fixed price delivery order awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract employs no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCY39Delivery Order
The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, valued at $2,654.34. This firm fixed-price delivery order, with an ultimate completion date of February 5, 2026, was awarded on a competitive basis without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed this order under its Corporate Office division and serves as the prime contractor. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant $999.99 billion Indefinite Delivery Contract with DLA Troop Support Medical through December 2031, which serves as the overarching vehicle enabling the company to supply comprehensive pharmaceutical products and medical supplies globally to military healthcare programs. AmerisourceBergen's pharmaceutical distribution capabilities position it as a critical vendor within the federal medical procurement ecosystem. The company maintains extensive experience fulfilling diverse federal medical supply requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for controlled pharmaceutical products reflects the company's specialized role in supporting military medical operations and demonstrates its continued competitiveness in meeting federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/3/26 |